Neurocrine Bioscience buy Wedbush
Start price
07.02.25
/
50%
€116.50
Target price
07.02.26
€142.21
Performance (%)
11.72%
Price
12.12.25
€130.15
Summary
This prediction is currently active. The prediction currently has a performance of 11.72%. This prediction currently runs until 07.02.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Wedbush from $157.00 to $147.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€123.35
31.07.26
31.07.26
12.93%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
-
06.05.26
06.05.26
22.90%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.25
16.12.24
16.12.24
€140.81
16.12.25
16.12.25
5.60%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-10.86%
30.05.25
30.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€127.63
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24